{"id":"beglan","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["LABA"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:28:15.913Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06282861","phase":"PHASE4","title":"ANTES B+ Clinical Trial","status":"TERMINATED","sponsor":"Fundacio Privada Mon Clinic Barcelona","startDate":"2024-02-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":48}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"ASTHMA"},{"count":2,"reaction":"CARDIAC FAILURE"},{"count":2,"reaction":"CARDIAC FAILURE CONGESTIVE"},{"count":2,"reaction":"RESPIRATORY TRACT INFECTION"},{"count":1,"reaction":"ANGINA PECTORIS"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"ATRIOVENTRICULAR BLOCK COMPLETE"},{"count":1,"reaction":"CONFUSIONAL STATE"},{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"DIABETES MELLITUS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Beglan","genericName":"Beglan","companyName":"Fundacio Privada Mon Clinic Barcelona","companyId":"fundacio-privada-mon-clinic-barcelona","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}